Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2010

Open Access 01-12-2010 | Case report

Case of a sigmoid colon cancer with metachronous metastases to the mesorectum and the abdominal wall

Authors: John Kalaitzis, George Filippou, Adamantia Zizi-Sermpetzoglou, Athanasios Marinis, Andreas Hadjimarcou, Nikolaos Paschalidis, Spyros Rizos

Published in: World Journal of Surgical Oncology | Issue 1/2010

Login to get access

Abstract

Backround

Sigmoid colon cancer metachronous metastases commonly occur in the liver and lungs with sporadic reports also to the spleen, stomach, thyroid gland, abdominal wall and upper urinary tract. This is a rare case of metachronous metastases invading the mesorectum and the abdominal wall.

Case presentation

A 72-year-old female underwent sigmoidectomy for stage I (T2N0 M0) sigmoid colon cancer in May 2008. In June 2009, an abdominal computed tomography scan revealed a tumor 2 cm in size at the lower anterior mesorectum and a second mass 2 cm in size at the anterior abdominal wall midline. Total colonoscopy showed no mucosal lesion. The serum carcinoembryonic antigen level was normal. A biopsy of the mesorectum tumor showed similar histologic characteristics with the primary tumor. Since no other site of recurrence was identified, an abdominoperineal resection was attempted. During the operation and after the removal of the incision recurrence, sinus bradycardia and signs of myocardial ischemia were noticed. A loop transverse colostomy was immediately perfomed and the operation was terminated. Postoperative cardiologic examination revealed an acute myocardium infract. Chemo-radiation of the mesorectum tumor and re-evaluation for surgical excision was decided.

Conclusion

Metachronous metastasis of the mesorectum from sigmoid colon cancer is extremely rare. Although patterns of lymphatic spread from rectal cancer to sigmoid colon have recently been demonstrated, there is no evidence of metachronous mesorectum invasion from sigmoid colon cancer. This could be the issue for future trials.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hoshino S, Yanauchi K, Mikami T, Shinohara T: Evaluation of risk factors for metachronous liver and lung metastasis in colorectal carcinoma. Med Bull Fukuoka Univ. 2007, 34 (4): 279-283. Hoshino S, Yanauchi K, Mikami T, Shinohara T: Evaluation of risk factors for metachronous liver and lung metastasis in colorectal carcinoma. Med Bull Fukuoka Univ. 2007, 34 (4): 279-283.
2.
go back to reference Rasim Gencosmanoglu, Fugen Aker, Gozde Kir, Nurdan Tozun: Isolated metachronous splenic metastasis from synchronous colon cancer. World J Surg Oncol. 2006, 4: 42-10.1186/1477-7819-4-42.CrossRef Rasim Gencosmanoglu, Fugen Aker, Gozde Kir, Nurdan Tozun: Isolated metachronous splenic metastasis from synchronous colon cancer. World J Surg Oncol. 2006, 4: 42-10.1186/1477-7819-4-42.CrossRef
3.
go back to reference Shirakawa S, Kaneda K, Fujiwara H, Nishimura T, Sendo H, Wada T, Kizaki T: Case of a sigmoid colon cancer with metachronous metastases of the stomach and the abdominal wall. Nippon Shokakibyo Gakkai Zasshi. 2009, 106 (5): 653-9.PubMed Shirakawa S, Kaneda K, Fujiwara H, Nishimura T, Sendo H, Wada T, Kizaki T: Case of a sigmoid colon cancer with metachronous metastases of the stomach and the abdominal wall. Nippon Shokakibyo Gakkai Zasshi. 2009, 106 (5): 653-9.PubMed
4.
go back to reference Mesko TW, Friedman J, Sendzischew H, Nixon DD: Rectal carcinoma metastatic to the thyroid gland. J Laryngol Otol. 1996, 110 (2): 192-5. 10.1017/S0022215100133158.CrossRefPubMed Mesko TW, Friedman J, Sendzischew H, Nixon DD: Rectal carcinoma metastatic to the thyroid gland. J Laryngol Otol. 1996, 110 (2): 192-5. 10.1017/S0022215100133158.CrossRefPubMed
5.
go back to reference Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med. 1998, 129 (1): 27-35.CrossRefPubMed Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med. 1998, 129 (1): 27-35.CrossRefPubMed
6.
go back to reference NCCN Clinical Practice Guidelines in Oncology ColonCancer V.3.2009. NCCN Clinical Practice Guidelines in Oncology ColonCancer V.3.2009.
7.
go back to reference Compton CC, Greene FL: The staging of colorectal cancer: 2004 and beyond. Ca Cancer J Clin. 2004, 54: 295-308. 10.3322/canjclin.54.6.295.CrossRefPubMed Compton CC, Greene FL: The staging of colorectal cancer: 2004 and beyond. Ca Cancer J Clin. 2004, 54: 295-308. 10.3322/canjclin.54.6.295.CrossRefPubMed
8.
go back to reference International Union Against Cancer (UICC): Colon and rectum. TNM classification of malignant tumors. Edited by: Sobin LH, Wittekind CH. 2002, New York, NY: Wiley, 72-76. 6 International Union Against Cancer (UICC): Colon and rectum. TNM classification of malignant tumors. Edited by: Sobin LH, Wittekind CH. 2002, New York, NY: Wiley, 72-76. 6
9.
go back to reference Compton CC, Fielding LP, Burgardt LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C: Prognostic factors in colorectal cancer. College of American pathologists consensus statement. Arch Pathol Lab Med. 2000, 124: 979-994.PubMed Compton CC, Fielding LP, Burgardt LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C: Prognostic factors in colorectal cancer. College of American pathologists consensus statement. Arch Pathol Lab Med. 2000, 124: 979-994.PubMed
10.
go back to reference Sobin HL, Greene FL: TNM classification. Clarification of number of regional lymph node for pN0. Cancer. 2001, 92 (2): 452-10.1002/1097-0142(20010715)92:2<452::AID-CNCR1342>3.0.CO;2-B.CrossRefPubMed Sobin HL, Greene FL: TNM classification. Clarification of number of regional lymph node for pN0. Cancer. 2001, 92 (2): 452-10.1002/1097-0142(20010715)92:2<452::AID-CNCR1342>3.0.CO;2-B.CrossRefPubMed
11.
go back to reference Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG: Colon cancer survival is associated with increasing number of lunph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003, 21: 2912-2919. 10.1200/JCO.2003.05.062.CrossRefPubMed Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG: Colon cancer survival is associated with increasing number of lunph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003, 21: 2912-2919. 10.1200/JCO.2003.05.062.CrossRefPubMed
12.
go back to reference Chaplin S, Scerottini G-P, Bosman F-T, Konstanda MT, Givel J-C: For patients with Duke's B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998, 83: 666-72. 10.1002/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.0.CO;2-I.CrossRef Chaplin S, Scerottini G-P, Bosman F-T, Konstanda MT, Givel J-C: For patients with Duke's B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998, 83: 666-72. 10.1002/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.0.CO;2-I.CrossRef
13.
go back to reference Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, Catalano PJ, Haller DG: Accuracy of determining nodal negativity in colorectal cancer on the basis of number of nodes retrieved on resection. Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, Catalano PJ, Haller DG: Accuracy of determining nodal negativity in colorectal cancer on the basis of number of nodes retrieved on resection.
14.
go back to reference Kobayashi Y, Fujita S, Yamaguchi T, Yamamoto S, Akasu T, Moriya Y: Optimum lymph node dissection in clinical T1 and clinical T2 colorectal cancer. Dis Colon Rectum. 2009, 52 (5): 942-9.CrossRefPubMed Kobayashi Y, Fujita S, Yamaguchi T, Yamamoto S, Akasu T, Moriya Y: Optimum lymph node dissection in clinical T1 and clinical T2 colorectal cancer. Dis Colon Rectum. 2009, 52 (5): 942-9.CrossRefPubMed
15.
go back to reference Canessa CE, Badía F, Fierro S, Fiol V, Háyek G: Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum. 2001, 44 (9): 1333-6. 10.1007/BF02234794.CrossRefPubMed Canessa CE, Badía F, Fierro S, Fiol V, Háyek G: Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum. 2001, 44 (9): 1333-6. 10.1007/BF02234794.CrossRefPubMed
16.
go back to reference Park IJ, Choi GS, Lim KH, Kang BM, Jun SH: Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer. Ann Surg. 2009, 249: 960-964. 10.1097/SLA.0b013e3181a57c8f.CrossRefPubMed Park IJ, Choi GS, Lim KH, Kang BM, Jun SH: Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer. Ann Surg. 2009, 249: 960-964. 10.1097/SLA.0b013e3181a57c8f.CrossRefPubMed
17.
go back to reference Reilly WT, Nelson H, Schroeder G, Wieand HS, Bolton J, O'Connell MJ: Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum. 1996, 39 (2): 200-7. 10.1007/BF02068076.CrossRefPubMed Reilly WT, Nelson H, Schroeder G, Wieand HS, Bolton J, O'Connell MJ: Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum. 1996, 39 (2): 200-7. 10.1007/BF02068076.CrossRefPubMed
Metadata
Title
Case of a sigmoid colon cancer with metachronous metastases to the mesorectum and the abdominal wall
Authors
John Kalaitzis
George Filippou
Adamantia Zizi-Sermpetzoglou
Athanasios Marinis
Andreas Hadjimarcou
Nikolaos Paschalidis
Spyros Rizos
Publication date
01-12-2010
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2010
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-8-17

Other articles of this Issue 1/2010

World Journal of Surgical Oncology 1/2010 Go to the issue